Romania's anti-trust body approves Medlife takeover of Medici's Group

The anti-trust body’s analysis revealed that the acquisition poses no significant threats to the national market and that there are no serious doubts regarding its compatibility with a regular competition environment, it said in a press release.

Medici’s has over 100,000 patients annually and over 40,000 permanent subscribers. It operates four clinics and 40 own consulting offices, a medical imaging laboratory, a laboratory analysis platform and over 200 own doctors and collaborators. The network invested a total 15 million euro ($15.8 million) in its development in the last 25 years. Its turnover rose by an annual 40% to 20.3 million lei ($4.3 million/ 4.1 million euro) last year.

Established in 1996, MedLife is among Romania’s largest healthcare providers, running 230 clinics, 15 hospitals, 4 maternities, 37 individual laboratories, 200 collection points, and 14 excellence centres. The network also collaborates with 170 medical clinics across Romania.

MedLife booked a net profit of 123 million lei in 2021, almost doubling its performance compared to the previous year.

Blue-chip MedLife’s shares traded 4.74% higher at 16.34 lei on the Bucharest Stock Exchange as of 1209 CET on Friday.

($=0.9504 euro)